All In MedTech

FDA Clearance Tracker · P100034-S014

NOVOCURE'S OPTUNE SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Feb 9, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Feb 9, 2016

Approved

Time to decision

172 days

Received Aug 21, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P100034-S014
Device name
NOVOCURE'S OPTUNE SYSTEM
Applicant location
Baar
Received
Aug 21, 2015
Decided
Feb 9, 2016
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P100034

Device type

Device class
Class III

Every decision under product code NZK

FDA's approval statement

As written in FDA's record.

Approval of the following changes to the post-approval study for the device: modification to enrollment criteria.

Source documents

Other decisions for Novocure, GmbH

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.